Merck & Co., Inc. R&D Expense 2007-2026 | MRK
Beta
What is r&d expense?
Research and development expense represents the costs incurred in discovering and developing new products, processes, or technologies.
What is Merck & Co., Inc.'s current r&d expense?
Merck & Co., Inc. (MRK) annual r&d expense for 2025 was $15.79B, a 11.98% decline from 2024. Merck & Co., Inc. r&d expense for the quarter ending March 31, 2026 was $12.59B.
What was Merck & Co., Inc.'s r&d expense in 2024?
Merck & Co., Inc. annual r&d expense for 2024 was $17.94B, a 41.25% decline from 2023.
What was Merck & Co., Inc.'s r&d expense in 2023?
Merck & Co., Inc. annual r&d expense for 2023 was $30.53B, a 125.35% increase from 2022.
What is Merck & Co., Inc.'s 5-year r&d expense CAGR?
Merck & Co., Inc. r&d expense grew at a compound annual growth rate (CAGR) of 3.34% from FY2020 to FY2025, going from $13.40B to $15.79B over 5 years.
R&D Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Declining
CAGR+3.3%
FY2020
$13.40B
→
FY2025
$15.79B
07080910111213141516171819202122232425
5 years selected
R&D Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $15.79B | -12.0% | 10-K |
| FY2024 | $17.94B | -41.2% | 10-K |
| FY2023 | $30.53B | +125.4% | 10-K |
| FY2022 | $13.55B | +10.6% | 10-K |
| FY2021 | $12.24B | -8.6% | 10-K |
| FY2020 | $13.40B | +37.8% | 10-K |
| FY2019 | $9.72B | -0.3% | 10-K |
| FY2018 | $9.75B | -5.7% | 10-K |
| FY2017 | $10.34B | +0.8% | 10-K |
| FY2016 | $10.26B | +53.1% | 10-K |
| FY2015 | $6.70B | -6.6% | 10-K |
| FY2014 | $7.18B | -4.3% | 10-K |
| FY2013 | $7.50B | -8.1% | 10-K |
| FY2012 | $8.17B | -3.5% | 10-K |
| FY2011 | $8.47B | -23.8% | 10-K |
| FY2010 | $11.11B | +90.1% | 10-K |
| FY2009 | $5.84B | +21.6% | 10-K |
| FY2008 | $4.80B | -1.6% | 10-K |
| FY2007 | $4.88B | - | 10-K |
Company: Merck & Co., Inc.Ticker: MRKSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →